191 related articles for article (PubMed ID: 27913539)
1. Prevention of central nervous system sequelae in sickle cell disease without evidence from randomized controlled trials: the case for a team-based learning collaborative.
DeBaun MR; King AA
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):632-639. PubMed ID: 27913539
[TBL] [Abstract][Full Text] [Related]
2. Central nervous system complications and management in sickle cell disease.
DeBaun MR; Kirkham FJ
Blood; 2016 Feb; 127(7):829-38. PubMed ID: 26758917
[TBL] [Abstract][Full Text] [Related]
3. How I treat and manage strokes in sickle cell disease.
Kassim AA; Galadanci NA; Pruthi S; DeBaun MR
Blood; 2015 May; 125(22):3401-10. PubMed ID: 25824688
[TBL] [Abstract][Full Text] [Related]
4. Sickle cell disease: primary stroke prevention.
Gebreyohanns M; Adams RJ
CNS Spectr; 2004 Jun; 9(6):445-9. PubMed ID: 15162093
[TBL] [Abstract][Full Text] [Related]
5. Secondary prevention of overt strokes in sickle cell disease: therapeutic strategies and efficacy.
DeBaun MR
Hematology Am Soc Hematol Educ Program; 2011; 2011():427-33. PubMed ID: 22160069
[TBL] [Abstract][Full Text] [Related]
6. Capacity Building for Primary Stroke Prevention Teams in Children Living With Sickle Cell Anemia in Africa.
Ghafuri DL; Covert Greene B; Musa B; Gambo A; Sani A; Abdullahi S; Wudil BJ; Bello-Manga H; Gambo S; Ghafuri M; Cassell H; Neville K; Kirkham F; Kassim AA; Aliyu MH; DeBaun MR; Jordan LC
Pediatr Neurol; 2021 Dec; 125():9-15. PubMed ID: 34563875
[TBL] [Abstract][Full Text] [Related]
7. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.
Yawn BP; Buchanan GR; Afenyi-Annan AN; Ballas SK; Hassell KL; James AH; Jordan L; Lanzkron SM; Lottenberg R; Savage WJ; Tanabe PJ; Ware RE; Murad MH; Goldsmith JC; Ortiz E; Fulwood R; Horton A; John-Sowah J
JAMA; 2014 Sep; 312(10):1033-48. PubMed ID: 25203083
[TBL] [Abstract][Full Text] [Related]
8. PRIMARY STROKE PREVENTION IN CHILDREN WITH SICKLE CELL ANEMIA LIVING IN AFRICA: THE FALSE CHOICE BETWEEN PATIENT-ORIENTED RESEARCH AND HUMANITARIAN SERVICE.
Debaun MR; Galadanci NA; Kassim AA; Jordan LC; Phillips S; Aliyu MH
Trans Am Clin Climatol Assoc; 2016; 127():17-33. PubMed ID: 28066035
[TBL] [Abstract][Full Text] [Related]
9. Lessons from the Stroke Prevention Trial in Sickle Cell Anemia (STOP) study.
Adams RJ
J Child Neurol; 2000 May; 15(5):344-9. PubMed ID: 10830201
[TBL] [Abstract][Full Text] [Related]
10. American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults.
DeBaun MR; Jordan LC; King AA; Schatz J; Vichinsky E; Fox CK; McKinstry RC; Telfer P; Kraut MA; Daraz L; Kirkham FJ; Murad MH
Blood Adv; 2020 Apr; 4(8):1554-1588. PubMed ID: 32298430
[TBL] [Abstract][Full Text] [Related]
11. An evidence-based approach to the treatment of adults with sickle cell disease.
Lottenberg R; Hassell KL
Hematology Am Soc Hematol Educ Program; 2005; ():58-65. PubMed ID: 16304360
[TBL] [Abstract][Full Text] [Related]
12. Developing a global agenda for sickle cell disease: report of an international symposium and workshop in Cotonou, Republic of Benin.
Odame I
Am J Prev Med; 2010 Apr; 38(4 Suppl):S571-5. PubMed ID: 20331960
[TBL] [Abstract][Full Text] [Related]
13. Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease.
Griessenauer CJ; Lebensburger JD; Chua MH; Fisher WS; Hilliard L; Bemrich-Stolz CJ; Howard TH; Johnston JM
J Neurosurg Pediatr; 2015 Jul; 16(1):64-73. PubMed ID: 25837886
[TBL] [Abstract][Full Text] [Related]
14. A primary care provider's guide to preventive and acute care management of adults and children with sickle cell disease.
Pack-Mabien A; Haynes J
J Am Acad Nurse Pract; 2009 May; 21(5):250-7. PubMed ID: 19432908
[TBL] [Abstract][Full Text] [Related]
15. Primary stroke prevention in Nigerian children with sickle cell disease (SPIN): challenges of conducting a feasibility trial.
Galadanci NA; Abdullahi SU; Tabari MA; Abubakar S; Belonwu R; Salihu A; Neville K; Kirkham F; Inusa B; Shyr Y; Phillips S; Kassim AA; Jordan LC; Aliyu MH; Covert BV; DeBaun MR
Pediatr Blood Cancer; 2015 Mar; 62(3):395-401. PubMed ID: 25399822
[TBL] [Abstract][Full Text] [Related]
16. Sickle cell disease.
Strouse J
Handb Clin Neurol; 2016; 138():311-24. PubMed ID: 27637966
[TBL] [Abstract][Full Text] [Related]
17. Adult emergency department patients with sickle cell pain crisis: a learning collaborative model to improve analgesic management.
Tanabe P; Artz N; Mark Courtney D; Martinovich Z; Weiss KB; Zvirbulis E; Hafner JW
Acad Emerg Med; 2010 Apr; 17(4):399-407. PubMed ID: 20370779
[TBL] [Abstract][Full Text] [Related]
18. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
Foy JM; Earls MF
Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
[TBL] [Abstract][Full Text] [Related]
19. Declining stroke rates in Californian children with sickle cell disease.
Fullerton HJ; Adams RJ; Zhao S; Johnston SC
Blood; 2004 Jul; 104(2):336-9. PubMed ID: 15054044
[TBL] [Abstract][Full Text] [Related]
20. Big strokes in small persons.
Adams RJ
Arch Neurol; 2007 Nov; 64(11):1567-74. PubMed ID: 17998439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
